Filing Details

Accession Number:
0001567619-22-012778
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-13 16:36:35
Reporting Period:
2022-06-09
Accepted Time:
2022-06-13 16:36:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1034842 Rigel Pharmaceuticals Inc RIGL Pharmaceutical Preparations (2834) 943248524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190279 R Raul Rodriguez Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd.
South San Francisco CA 94080
Ceo, President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-09 1,000,000 $0.69 1,391,776 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $0.67 to $0.70. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price.